On November 8, 2021 Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, reported that management will participate in three upcoming investor conferences (Press release, Zymeworks, NOV 8, 2021, View Source [SID1234594754]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Stifel 2021 Virtual Healthcare Conference, November 16th – 17th. Zymeworks is participating in a fireside chat on November 17th at 1:20 p.m. ET.
Jefferies London Healthcare Conference, November 18th – 19th. Zymeworks’ pre-recorded presentation will be available on the Zymeworks’ website listed below on November 18th.
Evercore ISI 4th Annual HEALTHCONx Virtual Conference, November 30th – December 1st. Zymeworks is participating in a fireside chat on November 30th at 3:05 p.m. ET.
The Stifel and Evercore fireside chats will be webcast live and available for replay on Zymeworks’ website at View Source